Neuren Pharmaceuticals Annual Report 2022

BOARD AND COMMITTEE ATTENDANCE The table below shows the number of Board and Committee meetings each Director was eligible to attend and attended during the financial year ended 31 December 2022: Board Audit and Risk Remuneration Director Held (i) Attended Held (i) Attended Held (i) Attended Patrick Davies 10 10 2 2 2 2 Dr Trevor Scott 10 10 2 2 2 2 Dianne Angus 10 10 2 2 2 2 Dr Jenny Harry 10 10 2 2 2 2 Jonathan Pilcher 10 10 - - - - (i) Number of meetings held during the time the Director was a member of the Board or Committee INTERESTS REGISTER The Company is required to maintain an interests register in which particulars of certain transactions and matters involving Directors must be recorded. There were no entries in this register during and since the end of 2022. INFORMATION USED BY DIRECTORS During the year the Board received no notices from Directors of the Company requesting to use Company information received in their capacity as Directors, which would not otherwise have been available to them. INDEMNIFICATION AND INSURANCE OF DIRECTORS AND OFFICERS Neuren has entered into a deed of indemnity, insurance and access with Directors and Officers, which provides that Directors and Officers generally will incur no monetary loss as a result of actions undertaken by them as Directors and Officers. The indemnity does not cover criminal liability or liability in respect of a breach of a director’s duty to act in good faith and in what the director believes to be the best interests of the Company or a breach of any fiduciary duty owed to the Company or a subsidiary. DONATIONS No donations were made by the Company or its subsidiary companies during the year (2021: $nil). REMUNERATION OF DIRECTORS 2022 Salary/fees $ Bonus $ Super- annuation $ Share based payments $ Total $ Non-Executive Directors Patrick Davies 125,000 - - - 125,000 Dr Trevor Scott 75,000 - - - 75,000 Dianne Angus 68,028 - 6,972 - 75,000 Dr Jenny Harry 68,028 - 6,972 - 75,000 336,056 - 13,944 - 350,000 Executive Directors Jonathan Pilcher 396,403 - 24,430 125,505 546,338 Total 732,459 - 38,374 125,505 896,338 ADD I T I ONA L I NFORMAT I ON Neuren Pharmaceuticals Limited Annual Repor t 2022 48

RkJQdWJsaXNoZXIy MjE2NDg3